Nutraceuticals: Should patients not be told or an unnecessary financial burden? With the expansion of the market for nutraceuticals and dietary supplements in Nepal , debates have increased about their registration, quality, price, recommendation, and sales and distribution. A patient goes to the hospital with general weakness, fatigue, or body aches. After an examination, the doctor recommends vitamins, minerals, omega-3, probiotics, or other supplements along with medicine. When it comes time to pay the bill for the medicine at the pharmacy, patients are shocked. Supplements are actually very expensive. And the question arises in their minds – are all these medicines not to be taken? The market for nutraceuticals and dietary supplements is expanding in Nepal. There is a constant debate about their use, registration, quality, price, medical recommendation, and sales and distribution. This raises the main question – are nutraceuticals a real need of patients or not? What are nutra...
India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...